Ryanodine receptors (RyRs) form a class of internal calcium channels in excitable tissues such as muscles and nerves in animals. These receptors play key roles in multiple signaling pathways in the body and are critical for maintaining cellular calcium homeostasis. With the advancement of science and technology, researchers have gained a deeper understanding of the structure and function of ryanidine receptors, which not only helps to understand normal physiological processes but also provides insights into some diseases.
There are three main subtypes of ryanidine receptors, including RyR1, RyR2, and RyR3, which differ according to the tissues in which they are expressed and the signaling pathways they participate in.
In non-mammalian vertebrates, two ryanidine receptor subtypes are commonly expressed, termed RyR-alpha and RyR-beta.RyR1 is mainly expressed in skeletal muscle, while RyR2 is mainly expressed in cardiac muscle and RyR3 is more widespread, especially in the brain.
Ryanidine receptors play a key role in the process of muscle contraction by mediating the release of calcium ions from the endoplasmic reticulum or sarcoplasmic reticulum where muscle is stored into the cell.
This process is called calcium-induced calcium release (CICR). In addition, the aggregation of ryanidine receptors can also lead to local fluctuations in intracellular calcium, namely calcium waves, which are crucial for many physiological processes.In skeletal muscle, ryanandine receptor activation occurs through physical coupling to dihydropyridine receptors, whereas in cardiac muscle, activation occurs primarily through a calcium-induced calcium release mechanism.
The ryanidine receptor is a multifunctional homotetramer whose structural complexity enables it to undergo a variety of allosteric regulation. With a molecular weight exceeding 2 megadaltons, these receptors are among the largest ion channels known.
This characteristic enables the ryanidine receptor to play its role in the regulation of calcium signals.The structural features of RyR are similar to the basic structure of the six-transmembrane ion channel superfamily, and show the characteristics of key regulatory domains connected by an extended α-helical rod.
Various agonists and antagonists of ryanidine receptors have been widely used in clinic or research. For example, ryandin can lock receptors in a half-open state at nanomolar concentrations, while micromolar concentrations completely close the channels.
The effects of these drugs are not only crucial in the treatment of heart disease, but also open up new prospects in the study of the functions of many nervous systems.Other compounds, such as dihydropyridines, caffeine, and cyclic AMP, are agonists of ryanidine receptors and can enhance their sensitivity to calcium.
Mutations in ryanidine receptors are associated with many diseases, such as mutations in RyR1, which are associated with malignant hyperthermia, arrhythmias, and neurodegenerative diseases such as Alzheimer's disease.
In addition, mutations in the RyR2 gene are also directly related to heart disease, making the study of ryanidine receptors key to understanding the key mechanisms of these diseases.When the body is exposed to certain volatile anesthetics, mutant RyR1 displays an increased affinity for calcium, which leads to excessive release of calcium and excessive energy consumption, thereby generating excess heat.